"I never miss an issue of Biotech Finances. It's an excellent vehicle for all the essential information about activity in the sector."
Frédéric Desdouits, Managing Partner at BIONEST- Healthcare Strategic Consulting and M&A.
Biotech Finances brings us every week the most important information about financial activity and transactions in the biotech sector in Europe. As capital investors we're able to find what we need in less than 10 minutes of reading per week. Bravo!"
Isabelle de Crémoux, General Partner, Director of Lifesciences Department, SEVENTURE
"Biotech Finances is the only specialized support system in France that gives in-depth information about the medical equipment sector, which is a sector in full development. This is why, for me, it is the best source of information about medtech."
Ismaël Nujurally, CEO, THERACLION
"I appreciate Biotech Finances because it offers both quick information and analysis."
Dr Gilles Avenard, CEO, BIOALLIANCE PHARMA
"In a sector where information seems to abound, every week Biotech Finances offers a selective, alert and sharp view on the strategy of European pharmaceutical companies and their economic environment. This double treatment, both scientific and business, of the news in life sciences is rare and makes this publication stand out. It is also an excellent decoding tool for professionals."
Bruno Arabian, CEO, MILESTONE
"Biotech Finances is created with an entrepreneurial spirit and brings together the views of different players in biotechnology financing. In addition to being a comprehensive source of information, it sheds light on what's going on in the background of the sector in Europe."
Jean-Yves Nothias, General Partner, BioConvergence Team, SOCIETE GENERALE ASSET MANAGEMENT
"For me, Biotech Finances is a unique source of information about the important participants and their strategies in biotech. Biotech Finances has the merit of being able to make a sometimes complex reality understandable in clear and simple words."
Stéphane Olmi , Manager, LAZARD FRERES
"I never miss an issue of Biotech Finances. It's an excellent vehicle for all the essential information about activity in the sector."
Frédéric Desdouits, Managing Partner at BIONEST- Healthcare Strategic Consulting and M&A.
